Takeda’s Dengue Vaccine Met Phase 3 Goals - PrecisionVaccinations

Takeda’s Dengue Vaccine Met Phase 3 Goals  PrecisionVaccinations

The pivotal Phase 3 clinical trial of dengue vaccine candidate TAK-003 was reported to have met the primary efficacy endpoint. This is important news since ...



Comments

Popular posts from this blog

22 Essential Oils for Skin Conditions and Types, and How to Use ...

Syphilis: Symptoms, Diagnosis, Treatment, and Prevention